The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[2-(Diethylamino)ethyl]-2-(pentan-3-yloxy)quinoline-4-carboxamide ID: ALA4588845
PubChem CID: 155567257
Max Phase: Preclinical
Molecular Formula: C21H31N3O2
Molecular Weight: 357.50
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC(CC)Oc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1
Standard InChI: InChI=1S/C21H31N3O2/c1-5-16(6-2)26-20-15-18(17-11-9-10-12-19(17)23-20)21(25)22-13-14-24(7-3)8-4/h9-12,15-16H,5-8,13-14H2,1-4H3,(H,22,25)
Standard InChI Key: CRJJDKZGBWUFMR-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
19.8299 -20.0253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8288 -20.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5368 -21.2538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5350 -19.6164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2436 -20.0217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2444 -20.8407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9529 -21.2478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6612 -20.8369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6565 -20.0148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9474 -19.6114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3705 -21.2428 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.0766 -20.8314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9430 -18.7943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6486 -18.3819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2332 -18.3894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7859 -21.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0734 -20.0142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6442 -17.5647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3498 -17.1524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3454 -16.3352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0510 -15.9229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6356 -15.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6312 -15.1132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0466 -15.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7795 -19.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4920 -20.8259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
11 12 1 0
10 13 1 0
13 14 1 0
13 15 2 0
12 16 1 0
12 17 1 0
14 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 1 0
22 23 1 0
21 24 1 0
17 25 1 0
16 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.50Molecular Weight (Monoisotopic): 357.2416AlogP: 3.87#Rotatable Bonds: 10Polar Surface Area: 54.46Molecular Species: BASEHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.04CX LogP: 4.19CX LogD: 2.54Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: -1.19
References 1. Musharrafieh R, Zhang J, Tuohy P, Kitamura N, Bellampalli SS, Hu Y, Khanna R, Wang J.. (2019) Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)., 62 (8): [PMID:30912944 ] [10.1021/acs.jmedchem.9b00115 ]